PRESS RELEASES
Subscribe to our latest press releases
Aperio Partners with HistoRx to Provide Integrated Fluorescence Whole Slide Imaging System
Fluorescence Scanner and Image Analysis Software Offer Complete Solution for Biomarker Discovery
Vista, CA and New Haven, CT – September 9, 2009 – Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, and HistoRx,
Inc., a leader in the emerging field of tissue-based assays for targeted patient treatment, have entered into a partnership to provide an integrated solution for whole-slide imaging with fluorescence.
The partnership integrates Aperio's new ScanScope® FL, a multi-slide fluorescence scanning system designed to meet the growing demand for multiplexing with fluorescent biomarkers and quantitative analysis, with HistoRx' AQUA® (Automated Quantitative Analysis) software for fluorescent image analysis that provides in-depth scientific insights from biomarker measurements. Aperio will be a value-added reseller of the AQUA software.
Aperio CEO Dirk G. Soenksen said, "With HistoRx, we see an opportunity to meet the growing trend in scientific research and drug discovery toward the use of fluorochrome-labeled tissue markers for diagnosis, treatment selection and monitoring in cancer."
HistoRx' AQUA image analysis technology can be used for quantitative assessment of protein expression in fixed tissue by measuring the intensity of expression in a particular cellular compartment, such as the cytoplasmic or nuclear compartment. The output of the analysis, called the AQUA score, can be correlated with other parameters such as disease detection, progression, response to therapy, or expression of proteins in alternate pathways. This technology will help to advance personalized medicine by identifying and validating new drug targets.
The AQUA analysis application will interface with Aperio's Spectrum Plus™ image and data management platform, giving customers a seamless experience digitizing, viewing and analyzing fluorescence slides.
"Partnering with the global leader in digital pathology is a significant expansion of the availability of HistoRx AQUA technology," said Rana K. Gupta, CEO of HistoRx. "We are pleased to collaborate with Aperio in helping pathologists worldwide improve their ability to identify correlations between biomarker expression and patient response to therapy."
About HistoRx
HistoRx, Inc. is a leading developer of tissue-based theranostic solutions to advance individualized patient care. The company's products and services are based on proprietary AQUA® technology for tissue biomarker analysis. AQUA® software is the only platform capable of precisely measuring protein biomarker concentration with subcellular resolution in tissue sections, enabling fully objective, standardized, reproducible, and automated analysis to guide targeted drug development and therapeutic decision making. HistoRx currently helps biopharmaceutical companies advance their product pipelines by generating valuable new insights into the safety and effectiveness of targeted therapeutics in development for cancer and other diseases, and is developing clinical assays based on these insights.
About Aperio
Aperio is the leading provider of digital pathology solutions in hospital and reference labs, academic medical centers, and biopharma institutions across the world. Today, our affordable and complete product portfolio is proven to lower costs, increase efficiencies, and enhance workflow in labs everywhere. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide™ slide sharing service for pathology, and image analysis tools and services. Aperio's products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information please visit www.aperio.com.
Contacts:
Jessica Witkowski
Aperio
760.539.1162
jessica@aperio.com
Myla Wagner
Myla Wagner Public Relations
925.736.7515
myla@mylawagnerpr.com
Kathleen Adams
HistoRx
203.498.7500
kathleen.adams@historx.com